Literature DB >> 525980

Chloramphenicol pharmacokinetics in hospitalized patients.

J R Koup, A H Lau, B Brodsky, R L Slaughter.   

Abstract

The apparent body clearance of chloramphenicol was investigated in 21 hospitalized adult patients on 27 occasions. Apparent body clearance was found to be significantly lower (1.99 +/- 1.49 ml/min per kg) in patients with total serum bilirubin concentrations of >1.5 mg/100 ml than in patients with serum bilirubin concentrations of </=1.5 mg/100 ml (3.57 +/- 1.72 ml/min per kg; P < 0.001). Serum protein binding of chloramphenicol was lower in cirrhotic patients (42.2 +/- 6.8% bound) than in normal adults (53.1 +/- 5.2% bound; P < 0.001). Low binding of chloramphenicol was also found in the serum of premature neonates (32.4 +/- 8.2% bound; P < 0.001). Reduced binding in neonates implies the need for a lower therapeutic range of total chloramphenicol concentration (3.5 to 13.9 mug/ml) compared with the usual adult range (5 to 20 mug/ml). Finally, three case reports are presented which demonstrate marked abnormalities and intrasubject variation in chloramphenicol clearance.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525980      PMCID: PMC352732          DOI: 10.1128/AAC.15.5.651

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  CHLORAMPHENICOL TOXICITY IN LIVER AND RENAL DISEASE.

Authors:  L G SUHRLAND; A S WEISBERGER
Journal:  Arch Intern Med       Date:  1963-11

2.  A CONTROLLED DOUBLE-BLIND STUDY OF THE HEMATOLOGIC TOXICITY OF CHLORAMPHENICOL.

Authors:  J L SCOTT; S M FINEGOLD; G A BELKIN; J S LAWRENCE
Journal:  N Engl J Med       Date:  1965-06-03       Impact factor: 91.245

3.  Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses.

Authors:  C F WEISS; A J GLAZKO; J K WESTON
Journal:  N Engl J Med       Date:  1960-04-21       Impact factor: 91.245

4.  An outbreak of neonatal deaths among term infants associated with administration of chloramphenicol.

Authors:  H LISCHNER; S J SELIGMAN; A KRAMMER; A H PARMELEE
Journal:  J Pediatr       Date:  1961-07       Impact factor: 4.406

5.  Fatal circulatory collapse in premature infants receiving chloramphenicol.

Authors:  L E BURNS; J E HODGMAN; A B CASS
Journal:  N Engl J Med       Date:  1959-12-24       Impact factor: 91.245

6.  Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients.

Authors:  R J Sawchuk; D E Zaske
Journal:  J Pharmacokinet Biopharm       Date:  1976-04

7.  Elimination of chloramphenicol and thiamphenicol in subjects with cirrhosis of the liver.

Authors:  F Azzollini; A Gazzaniga; E Lodola; R Natangelo
Journal:  Int J Clin Pharmacol       Date:  1972-06

8.  Chloramphenicol-associated encephalopathy.

Authors:  P H Levine; W Regelson; J F Holland
Journal:  Clin Pharmacol Ther       Date:  1970 Mar-Apr       Impact factor: 6.875

9.  Delayed clearance of chloramphenicol from serum in patients with hematologic toxicity.

Authors:  L G Suhrland; A S Weisberger
Journal:  Blood       Date:  1969-10       Impact factor: 22.113

10.  Characteristic properties of fetal human albumin (Alb F) in isomerization equilibrium.

Authors:  K Miyoshi; K Saijo; Y Kotani; T Kashiwagi; H Kawai
Journal:  Tokushima J Exp Med       Date:  1966-11
View more
  9 in total

1.  Microdialysis sampling for determination of plasma protein binding of drugs.

Authors:  A M Herrera; D O Scott; C E Lunte
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

2.  Decreased chloramphenicol clearance in malnourished Ethiopian children.

Authors:  M Ashton; P Bolme; E Alemayehu; M Eriksson; L Paalzow
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.

Authors:  Nusaibah Abdul Rahim; Soon-Ee Cheah; Matthew D Johnson; Heidi Yu; Hanna E Sidjabat; John Boyce; Mark S Butler; Matthew A Cooper; Jing Fu; David L Paterson; Roger L Nation; Phillip J Bergen; Tony Velkov; Jian Li
Journal:  J Antimicrob Chemother       Date:  2015-05-28       Impact factor: 5.790

4.  Rapid estimation of chloramphenicol clearance in infants and children.

Authors:  J R Koup; C M Sack; A L Smith; N N Neely; M Gibaldi
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.

Authors:  P J Ambrose
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

6.  Comparison of cefamandole, cephalothin, ampicillin, and chloramphenicol in experimental Escherichia coli meningitis.

Authors:  T R Beam; J C Allen
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

7.  Chloramphenicol clearance in typhoid fever: implications for therapy.

Authors:  Z A Bhutta; S K Niazi; A Suria
Journal:  Indian J Pediatr       Date:  1992 Mar-Apr       Impact factor: 1.967

8.  Azithromycin and Chloramphenicol Diminish Neutrophil Extracellular Traps (NETs) Release.

Authors:  Weronika Bystrzycka; Aneta Manda-Handzlik; Sandra Sieczkowska; Aneta Moskalik; Urszula Demkow; Olga Ciepiela
Journal:  Int J Mol Sci       Date:  2017-12-08       Impact factor: 5.923

9.  Pharmacokinetics of anti-infectious reagents in silkworms.

Authors:  Hiroshi Hamamoto; Ryo Horie; Kazuhisa Sekimizu
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.